1-3 of 3
Francis A. Ayuk
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chimeric antigen receptor T-cell therapy and fludarabine: precision dosing imperatives

Clinical Trials & Observations
Sebastian G. Wicha, Eva M. A. Wansing, Adrin Dadkhah, Francis A. Ayuk, Nicolaus M. Kröger, Claudia Langebrake
Journal: Blood Advances
Blood Adv (2024) 8 (3): 797–798.
https://doi.org/10.1182/bloodadvances.2023012068
Published: 2024
Journal Articles

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study

Maria-Luisa Schubert, Wolfgang A. Bethge, Francis A. Ayuk, Malte von Bonin, Vladan Vucinic, Eva Marie Wagner-Drouet, Marion Subklewe, Claudia D. Baldus, Bertram Glass, Reinhard Marks, Dimitrios Mougiakakos, Roland Schroers, Matthias Stelljes, Max S. Topp, Gerald Wulf, Nicolaus Kröger, Peter Dreger
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6191–6195.
https://doi.org/10.1182/bloodadvances.2023011203
Published: 2023
Includes: Supplemental data
Journal Articles

Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting

Clinical Trials & Observations
Francis A. Ayuk, Carolina Berger, Anita Badbaran, Tatjana Zabelina, Tanja Sonntag, Kristoffer Riecken, Maria Geffken, Dominic Wichmann, Christian Frenzel, Guenther Thayssen, Silke Zeschke, Nicolaus Kröger, Boris Fehse
Journal: Blood Advances
Blood Adv (2021) 5 (11): 2523–2527.
https://doi.org/10.1182/bloodadvances.2020003959
Published: 2021
Includes: Supplemental data